We report a 40-year-old man who noticed difficulty in standing on his tiptoe from approximately 36 years-old. He presented with selective calf muscle weakness on flexion. The serum creatine kinase (CK) level slightly increased to 569IU/l. Muscle computed tomography (CT) revealed selective gastrocnemius and soleus muscle atrophy with fat tissue replacement. A biopsy of the left gastrocnemius muscle revealed a marked variation in muscle fiber size and some necrotic and regenerating fibers. Immunohistochemical analysis using an anti-dysferlin antibody showed a faint and irregular immunostaining of the muscle surface membrane and abnormal immunoreactive depositions in the cytoplasm, although normal dysferlin content was detected by Western blotting. The sequence analysis of all exons of the dysferlin gene revealed no responsible mutations. The case had clinical and pathological findings similar to those of Miyoshi myopathy. The present study indicates that there may be a secondary abonormality of dysferlin derived from some other factors in patients with clinical and pathological findings similar to those of Miyoshi myopathy. The mechanism of dysferlin expression should be elucidated to obtain a conclusive pathogenetic mechanism underlying this disorder.

Download full-text PDF

Source

Publication Analysis

Top Keywords

dysferlin gene
8
clinical pathological
8
pathological findings
8
findings miyoshi
8
miyoshi myopathy
8
muscle
7
dysferlin
6
patient distal
4
distal muscular
4
muscular dystrophy
4

Similar Publications

Chronic pain as a presenting feature of dysferlinopathy.

Neuromuscul Disord

December 2024

Service de Neuromyologie, Centre de référence des maladies neuromusculaires Nord/Est/Ile de France Institut de Myologie, Sorbonne Université, APHP, Paris, France. Electronic address:

Dysferlinopathies, caused by mutations in the dysferlin gene (DYSF) encoding the dysferlin protein, are a clinically heterogeneous group of autosomal recessive muscular dystrophies whose phenotypic spectrum is still evolving. Here we described a patient reporting diffuse muscular pain non related to physical exercise, mimicking fibromyalgic syndrome. Electroneuromyography was normal.

View Article and Find Full Text PDF

Dystrophy-associated fer-1-like protein (dysferlin) conducts plasma membrane repair. Mutations in the DYSF gene cause a panoply of genetic muscular dystrophies. We targeted a frequent loss-of-function, DYSF exon 44, founder frameshift mutation with mRNA-mediated delivery of SpCas9 in combination with a mutation-specific sgRNA to primary muscle stem cells from two homozygous patients.

View Article and Find Full Text PDF

Ribozymes are small catalytic RNA sequences capable of nucleotide-specific self-cleavage found widespread in nature. Ribozyme cleavage generates distinct 2',3'-phosphate and 5'-hydroxyl termini that resemble substrates for recently characterized RNA repair pathways in cells. We report that ribozyme cleavage of two separate mRNAs activated their scarless trans-ligation and translation into full-length protein in eukaryotic cells, a process that we named StitchR (for Stitch RNA).

View Article and Find Full Text PDF
Article Synopsis
  • Miyoshi myopathy (MM) is a rare genetic disorder due to mutations in the dysferlin gene, linked to muscle degeneration and recognized as the same disease as Lower Girdle Muscular Dystrophy R2 (LGMD2B).
  • A 44-year-old male patient started experiencing symptoms at 19, including difficulties with stairs and toe-standing, leading to observable muscle atrophy and walking issues over the years.
  • The diagnosis was confirmed through genetic testing, revealing a mutation in the DYSF gene, and highlights the critical role of genetic diagnostics and the need for further research in muscular dystrophies.*
View Article and Find Full Text PDF

Comprehensive Proteomic Analysis of Dysferlinopathy Unveiling Molecular Mechanisms and Biomarkers Linked to Pathological Progression.

CNS Neurosci Ther

October 2024

Department of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China.

Article Synopsis
  • This study aimed to enhance the understanding of dysferlinopathy by using high-resolution proteomics to analyze muscle biopsies and link protein expression changes with musculoskeletal pathology.
  • Researchers examined tissue samples from 15 dysferlinopathy patients and age-matched controls, employing advanced techniques like TMT-labeled LC-MS/MS for proteomic profiling and various network analyses.
  • The findings revealed 1600 differentially expressed proteins associated with dysferlinopathy, highlighting dysregulated pathways related to metabolism, immune response, and muscle function, and identifying key proteins linked to disease severity and muscle damage.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!